09.06.2012 • NewsGermanyEUPricing

Drugmakers Slam "Punitive" German Pricing Measures

The pharmaceutical industry hit out on Friday at "punitive" measures introduced recently by Germany to rein in medicine costs, underscoring the growing pressure being felt by companies across Europe as governments cut healthcare budgets.

Manufacturers argue that unless Germany changes course its citizens will lose access to innovative modern medicines that are widely available in other countries.

"Recent years have seen the introduction of a series of punitive measures in Germany," Richard Bergstrom, director general of the European Federation of Pharmaceutical Industries and Associations said in a statement.

"Germany has traditionally led the rest of Europe in providing quick access to new medicines for its citizens and recognising the value of new medicines and vaccines. This position is now under serious threat."

Drugmakers are particularly concerned at three changes in Germany in recent years - the introduction of a mandatory 16% price rebate; a reference pricing system linking German drug prices to those in countries like Greece; and an assessment system tying the price of new medicines to those of generics.

The warning on Germany comes in the same week as drug companies in Britain expressed concerns about a radical shake-up of Britain's drug pricing system from 2014.

In southern Europe, companies also face billions of euros in unpaid bills for medicines in Spain, Greece, Italy and Portugal - the countries at the centre of the euro zone crisis - making Europe an increasingly difficult marketplace.

Industry executives, including the chief executives of GlaxoSmithKline and Bayer, have recently warned that Europe is becoming less attractive and risks being relegated in importance compared to the two other main developed markets, the United States and Japan.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.